Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease

J Ora, A Coppola, M Cazzola, L Calzetta… - Journal of …, 2020 - Taylor & Francis
Introduction Bronchodilators are the cornerstone of chronic obstructive pulmonary disease
(COPD) therapy and long-acting muscarinic antagonists (LAMAs) as a mono or combination …

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease.

J Ora, A Coppola, M Cazzola, L Calzetta… - Journal of …, 2020 - europepmc.org
Expert Opinion: Research on LAMA seems to have come to a standstill, the few new
molecules under study do not show distinctive characteristics compared to the previous …

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

J Ora, A Coppola, M Cazzola, L Calzetta… - Journal of …, 2020 - dovepress.com
Expert Opinion: Research on LAMA seems to have come to a standstill, the few new
molecules under study do not show distinctive characteristics compared to the previous …

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

J Ora, A Coppola, M Cazzola… - Journal of …, 2020 - search.proquest.com
Introduction: Bronchodilators are the cornerstone of chronic obstructive pulmonary disease
(COPD) therapy and long-acting muscarinic antagonists (LAMAs) as a mono or combination …

[HTML][HTML] Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

J Ora, A Coppola, M Cazzola, L Calzetta… - Journal of …, 2020 - ncbi.nlm.nih.gov
Expert Opinion: Research on LAMA seems to have come to a standstill, the few new
molecules under study do not show distinctive characteristics compared to the previous …

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease.

J Ora, A Coppola, M Cazzola, L Calceta… - Journal of Experimental …, 2020 - go.gale.com
Introduction: Bronchodilators are the cornerstone of chronic obstructive pulmonary disease
(COPD) therapy and long-acting muscarinic antagonists (LAMAs) as a mono or combination …

Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease

J Ora, A Coppola, M Cazzola, L Calzetta… - JOURNAL OF …, 2020 - air.unipr.it
Introduction: Bronchodilators are the cornerstone of chronic obstructive pulmonary disease
(COPD) therapy and long-acting muscarinic antagonists (LAMAs) as a mono or combination …

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

J Ora, A Coppola, M Cazzola, L Calzetta… - JOURNAL OF …, 2020 - art.torvergata.it
Bronchodilators are the cornerstone of chronic obstructive pulmonary disease (COPD)
therapy and long-acting muscarinic antagonists (LAMAs) as a mono or combination …

Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease

J Ora, A Coppola, M Cazzola… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Bronchodilators are the cornerstone of chronic obstructive pulmonary disease
(COPD) therapy and long-acting muscarinic antagonists (LAMAs) as a mono or combination …